TCP
LPCN icon

Tourbillon Capital Partners’s Lipocine LPCN Stock Holding History

Tourbillon Capital Partners’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-26,471
Closed -$2.75M – 103
2014
Q2 		$2.75M Buy
+26,471
New +$3.17M 0.16% 61

Other funds holding LPCN

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
DMAM
Del Mar Asset Management New York $76.5M AUM 20.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tourbillon Capital Partners's LPCN Position: Q3 2014 in Review

Tourbillon Capital Partners sold out of Lipocine (LPCN) in Q3 2014, closing a stake of 26,471 shares — an estimated $2.75M sold.

Tourbillon Capital Partners first reported a position in LPCN in Q2 2014 and held it in 1 quarter. The position peaked at $2.75M in Q2 2014. 17 funds tracked by Wall St. Rank hold LPCN as of Q3 2014.

  • Tourbillon Capital Partners reported no remaining Lipocine position as of Q3 2014 after selling out during the quarter.
  • Tourbillon Capital Partners sold 26,471 Lipocine shares in Q3 2014, an estimated $2.75M.
  • Tourbillon Capital Partners first reported a position in Lipocine in Q2 2014 and held it in 1 quarter.
  • Tourbillon Capital Partners's Lipocine position peaked at $2.75M in Q2 2014.
  • 17 funds tracked by Wall St. Rank held Lipocine as of Q3 2014.

Based on Tourbillon Capital Partners's 13F filing for Q3 2014, filed 14 Nov 2014.